By
Drug Target Review2025-07-28T08:30:15
Researchers in China have developed a next-generation CAR-T cell therapy armed with nanogels that can penetrate the dense barriers of solid tumours. This addresses a major limitation in the treatment of solid cancers with immunotherapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-15T09:36:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2025-05-14T14:30:00
Sponsored by Abzena
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2025-09-18T12:00:00
Sponsored by Benchling
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
Site powered by Webvision Cloud